Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00ZYP
|
||||
| Former ID |
DIB018421
|
||||
| Drug Name |
[3H]TBZOH
|
||||
| Synonyms |
[3H]-TBZOH ; alpha-[O-methyl-3H]dihydrotetrabenazine; [3H]dihydrotetrabenazine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [468005] | ||
| Formula |
C19H29NO3
|
||||
| InChI |
InChI=1S/C19H29NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16-17,21H,5-7,10-11H2,1-4H3
|
||||
| InChIKey |
WEQLWGNDNRARGE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Synaptic vesicle amine transporter | Target Info | Inhibitor | [534267] | |
| PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
| 5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathway | |||||
| CCKR signaling map ST | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.